(FY)Jun 30, 2023 | (FY)Jun 30, 2022 | |
---|---|---|
Operating cash flow (direct method) | ||
Cash income from operating activities | 2K | |
Other cash income from operating activities | ---- | --2K |
Cash paid | -20.12%-546.3K | -454.8K |
Payments to suppliers for goods and services | -20.12%-546.3K | ---454.8K |
Direct interest received | 4,018.44%76.15K | --1.85K |
Operating cash flow | -4.26%-470.15K | ---450.95K |
Investing cash flow | ||
Cash flow from continuing investing activities | 19.06%-1.74M | -2.14M |
Capital expenditure reported | 19.10%-1.73M | ---2.14M |
Net PPE purchase and sale | -145.40%-5.02K | ---2.04K |
Net other investing changes | ---- | ---3.1K |
Cash from discontinued investing activities | ||
Investing cash flow | 19.06%-1.74M | ---2.14M |
Financing cash flow | ||
Cash flow from continuing financing activities | -100.32%-23.32K | 7.37M |
Net issuance payments of debt | ---- | ---151.6K |
Net common stock issuance | ---- | --8M |
Net other financing activities | 95.14%-23.32K | ---479.75K |
Cash from discontinued financing activities | ||
Financing cash flow | -100.32%-23.32K | --7.37M |
Net cash flow | ||
Beginning cash position | 6,388.24%4.85M | --74.73K |
Current changes in cash | -146.68%-2.23M | --4.77M |
End cash Position | -45.96%2.62M | --4.85M |
Free cash from | 14.90%-2.21M | ---2.59M |
Accounting Standards | US-GAAP | US-GAAP |
No Data